Equities Analysts Offer Predictions for HSCS Q3 Earnings

Heart Test Laboratories, Inc. (NASDAQ:HSCSFree Report) – Investment analysts at Ascendiant Capital Markets issued their Q3 2025 earnings estimates for Heart Test Laboratories in a research note issued on Monday, January 20th. Ascendiant Capital Markets analyst L. Ward anticipates that the company will post earnings per share of ($2.41) for the quarter. The consensus estimate for Heart Test Laboratories’ current full-year earnings is ($9.82) per share. Ascendiant Capital Markets also issued estimates for Heart Test Laboratories’ Q4 2025 earnings at ($2.46) EPS, FY2025 earnings at ($9.82) EPS, Q1 2026 earnings at ($2.18) EPS, Q2 2026 earnings at ($2.11) EPS, Q3 2026 earnings at ($2.13) EPS, Q4 2026 earnings at ($1.93) EPS and FY2026 earnings at ($8.35) EPS.

Separately, Maxim Group reiterated a “buy” rating and issued a $12.00 price target on shares of Heart Test Laboratories in a research note on Wednesday, December 18th.

Read Our Latest Report on Heart Test Laboratories

Heart Test Laboratories Trading Up 0.6 %

NASDAQ HSCS opened at $3.49 on Wednesday. Heart Test Laboratories has a 12 month low of $2.36 and a 12 month high of $18.50. The company has a current ratio of 1.72, a quick ratio of 1.52 and a debt-to-equity ratio of 0.01. The stock has a 50 day moving average of $3.43 and a 200-day moving average of $3.51. The company has a market cap of $3.42 million, a PE ratio of -0.44 and a beta of 2.90.

Heart Test Laboratories (NASDAQ:HSCSGet Free Report) last announced its quarterly earnings data on Monday, December 16th. The company reported ($2.27) earnings per share for the quarter, beating the consensus estimate of ($2.30) by $0.03. During the same period in the prior year, the firm posted ($15.92) earnings per share.

Heart Test Laboratories Company Profile

(Get Free Report)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.

Featured Articles

Earnings History and Estimates for Heart Test Laboratories (NASDAQ:HSCS)

Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.